Table IV.
HLA-ABDR allele | MS group frequency, %, n=50 | Control group frequency, %, n=50 | P-value | Odds ratio | 95% confidence interval | Pc |
---|---|---|---|---|---|---|
A19 | ||||||
A29 | 4 | 6 | 0.516 | 1.532 | 0.419–5.603 | |
A30 | 8 | 3 | 0.120 | 2.812 | 0.724–10.924 | |
A31 | 2 | 0 | 0.490 | |||
A32 | 9 | 9 | 1 | 1 | 0.379–2.634 | |
A33 | 3 | 2 | 1 | 1.516 | 0.248–9.271 | |
A2 | 20 | 17 | 0.583 | 1.221 | 0.597–2.497 | |
A9 | ||||||
A23 | 4 | 3 | 0.999 | 1.347 | 0.294–6.180 | |
A24 | 16 | 5 | 0.011 | 3.619 | 1.271–10.303 | 0.022 |
B35 | 12 | 3 | 0.015 | 4.409 | 1.204–16.141 | 0.345 |
B40 | 7 | 3 | 0.195 | 2.434 | 0.611–9.694 | |
B60 | 1 | 0 | 1 | |||
B61 | 2 | 1 | 1 | 2.020 | 0.180–22.646 | |
B5 | ||||||
B51 | 14 | 7 | 0.106 | 2.163 | 0.834–5.612 | |
B52 | 3 | 7 | 0.194 | 2.434 | 0.611–9.694 | |
DR3 | ||||||
DR17 | 15 | 15 | 1 | 1 | 0.460–2.173 | |
DR18 | 2 | 1 | 1 | 2.020 | 0.180–22.646 | |
DR4 | 16 | 11 | 0.300 | 1.541 | 0.676–3.512 | |
DR5 | ||||||
DR11 | 15 | 11 | 0.399 | 1.428 | 0.621–3.284 |
HLA, human leukocyte antigen; MS, multiple sclerosis; Pc, corrected P-value.